Sonida Senior Living, Inc.

NYSE:SNDA

Medical - Care Facilities

Healthcare
$32.42 +1.12%

+$0.39 today

Market cap
$1.59B
Beta
0.78
P/E (TTM)
-6.4
EPS (TTM)
-$5.49
52W Low $23.66High $39.66

Volume 0.50M

Average 0.64M

SNDA Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Sonida Senior Living, Inc.NYSE: SNDA

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How SNDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for SNDA, versus a peer median of 8.9%.
SNDA Competitors
Research & Development for SNDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYSo-Young International Inc.LTM Mar 2026CN¥128.61M CNY-18.4%-17.2%7.8%
CMPSCOMPASS Pathways plcLTM Mar 2026$110.07M USD-12.0%+22.1%—
VREXVarex Imaging CorporationLTM Apr 2026$89.5M USD+0.1%+5.8%10.4%
FULCFulcrum Therapeutics, Inc.LTM Mar 2026$56.78M USD+0.2%-9.9%—
OCGNOcugen, Inc.LTM Mar 2026$41.48M USD+19.1%-10.9%928.9%
ANGOAngioDynamics, Inc.LTM Feb 2026$27.86M USD+5.7%-5.2%8.9%
LABStandard BioTools Inc.LTM Mar 2026$22.48M USD-43.6%-11.4%26.1%
SNDASonida Senior Living, Inc.LTM Mar 2026$0 USD——0.0%
TOIThe Oncology Institute, Inc.LTM Mar 2026$0 USD——0.0%
CYHCommunity Health Systems, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding SNDA) —+0.1%-9.9%8.9%

Competitors are the stored peer set for SNDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue234.72M238.43M255.32M304.33M381.14M
Cost of Revenue40.9M27.37M21.1M33.1M411.51M
Gross Profit193.82M211.06M234.22M271.23M(30.37M)
Gross Margin82.6%88.5%91.7%89.1%-8.0%
Research & Development00000
Selling, General & Admin32.33M30.29M32.2M40M39.85M
Operating Expenses227.47M240.37M249.41M286.06M27.84M
Depreciation & Amortization37.87M38.45M39.89M44.05M56.77M
EBITDA201.29M17.16M55.15M78M23.24M
EBITDA Margin85.8%7.2%21.6%25.6%6.1%
Operating Income(33.65M)(29.31M)(15.19M)(14.83M)(58.21M)
Operating Margin-14.3%-12.3%-5.9%-4.9%-15.3%
Interest Income6K235K608K1.68M2.1M
Interest Expense37.23M33.03M36.12M36.99M38.64M
Other Income / Expenses159.84M(25.01M)(5.67M)11.79M(13.96M)
Income Before Tax126.19M(54.32M)(20.85M)(3.04M)(72.16M)
Pre-Tax Margin53.8%-22.8%-8.2%-1.0%-18.9%
Income Tax Expense583K86K253K239K330K
Net Income125.61M(54.4M)(21.11M)(2.06M)(70.78M)
Net Margin53.5%-22.8%-8.3%-0.7%-18.6%
EPS (Basic)38.24(9.27)(3.85)(0.54)(4.22)
EPS (Diluted)37.92(9.27)(3.85)(0.54)(4.22)
Weighted Avg Shares2.75M6.36M6.79M14.11M18.09M
Weighted Avg Shares (Diluted)2.77M6.36M6.79M14.11M18.09M

Sonida Senior Living, Inc.

NYSE:SNDA

Intrinsic Alpha fair value

Locked

Current Price

$32.42

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.